Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility

Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563–572 (2002).

Sahai, E. Illuminating the metastatic process. Nature Rev. Cancer 7, 737–749 (2007).

Friedl, P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16, 14–23 (2004).

Leivonen, S. K. & Kahari, V. M. Transforming growth factor-β signaling in cancer invasion and metastasis. Int. J. Cancer 121, 2119–2124 (2007).

Lesko, E. & Majka, M. The biological role of HGF-MET axis in tumor growth and development of metastasis. Front. Biosci. 13, 1271–1280 (2008).

Wells, A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res 78, 31–101 (2000).

Levy, L. & Hill, C. S. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17, 41–58 (2006).

Nicholson, R. I., Gee, J. M. & Harper, M. E. EGFR and cancer prognosis. Eur. J. Cancer 37 Suppl 4, S9–S15 (2001).

Fox, S. B. & Harris, A. L. The epidermal growth factor receptor in breast cancer. J. Mammary Gland Biol. Neoplasia 2, 131–141 (1997).

Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Naturet Rev. Cancer 3, 807–821 (2003).

Donovan, J. & Slingerland, J. Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res. 2, 116–124 (2000).

Wakefield, L. M. & Roberts, A. B. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22–29 (2002).

Jakowlew, S. B. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev. 25, 435–457 (2006).

Zavadil, J. & Bottinger, E. P. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24, 5764–5774 (2005).

Vincent-Salomon, A. & Thiery, J. P. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 5, 101–106 (2003).

Kokkinos, M. I. et al. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs 185, 191–203 (2007).

Condeelis, J. & Segall, J. E. Intravital imaging of cell movement in tumours. Nature Rev. Cancer 3, 921–930 (2003).

Wyckoff, J. B., Jones, J. G., Condeelis, J. S. & Segall, J. E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60, 2504–2511 (2000).

ten Dijke, P. & Hill, C. S. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29, 265–273 (2004).

Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649–2656 (2007).

Philippar, U. et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell 15, 813–828 (2008).

Sahai, E. et al. Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol. 5, 14 (2005).

Xue, C. et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 66, 192–197 (2006).

Dennler, S. et al. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091–3100 (1998).

Schmierer, B. & Hill, C. S. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor β-dependent nuclear accumulation of Smads. Mol. Cell Biol. 25, 9845–9858 (2005).

Shaner, N. C. et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nature Biotechnol. 22, 1567–1572 (2004).

Mi, Z. et al. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J. Biol. Chem. 279, 46659–46667 (2004).

Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S. & Sahai, E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 16, 1515–1523 (2006).

Padua, D. et al. TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66–77 (2008).

Welch, D. R., Fabra, A. & Nakajima, M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl Acad. Sci. USA 87, 7678–7682 (1990).

Goswami, S. et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278–5283 (2005).

Gupta, G. P. et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446, 765–770 (2007).

Kang, Y. et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl Acad. Sci. USA 102, 13909–13914 (2005).

Nicolas, F. J., De Bosscher, K., Schmierer, B. & Hill, C. S. Analysis of Smad nucleocytoplasmic shuttling in living cells. J. Cell Sci. 117, 4113–4125 (2004).

Gilles, C. et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res. 63, 2658–2664 (2003).

Wong, C. et al. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β. Mol. Cell Biol. 19, 1821–1830 (1999).